Elekta AB announced that it has sold its 7.3 percent of the outstanding common stock in ViewRay, Inc. Elekta has no remaining shares in ViewRay after the transaction..
STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction.
The shares in ViewRay were purchased in a public offering in December 2019 at USD 3.13 per share and sold today at USD 4.65 per share. The proceeds from the sale were approximately USD 53 million, resulting in a gain of approximately USD 17.5 million. The gain will be booked in Elekta’s third quarter 2020/21.
For further information, please contact:
Mattias Thorsson, VP Corporate Communications
Tel: +46 70 865 8012
e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25
e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time
This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on January 22, 2021. (REGMAR)
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/elekta/r/elekta-divests-its-stake-in-viewray,c3272256
The following files are available for download:
View original content:http://www.prnewswire.com/news-releases/elekta-divests-its-stake-in-viewray-301213035.html
SOURCE Elekta
Company Codes: Berlin:EJXB, OTC-PINK:EKTAY, Bloomberg:EKTAB@SS, ISIN:SE0000163628, LSE:0O5H, Mexico:EKTAB, OTC-PINK:EKTAF, RICS:EKTAB.ST, Dusseldorf:EJXB, Frankfurt:EJXB, Munich:EJXB, Stockholm:EKTAB, Stuttgart:EJXB
